SCHEMBL4393097

SCHEMBL4393097

CC(=O)N1CCN(CCC(=O)N2CCC(=NOCc3cccc(C(F)(F)F)c3)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
MEN1 O00255 2/20 0.43
FAAH O00519 1/20 0.40
MAOB P27338 2/20 0.39
CARM1 Q86X55 1/20 0.39
PRMT6 Q96LA8 1/20 0.39
MC4R P32245 1/20 0.39
POLB P06746 3/20 0.39
LMNA P02545 2/20 0.39
MAPT P10636 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
NR1H4 Q96RI1 1/20 0.39
KCNK3 O14649 1/20 0.39
TRPV4 Q9HBA0 1/20 0.39
RORC P51449 1/20 0.39
HTR1A P08908 1/20 0.38
HTR7 P34969 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8212151 0.93 KMT2A (0.45) KMT2AMEN1FAAHMAOBCARM1
Hydrochloric Acid SCHEMBL4383617 0.92 KMT2A (0.44) KMT2AMEN1FAAHMAOBCARM1
SCHEMBL8221599 0.91 KMT2A (0.45) KMT2AMEN1FAAHCARM1PRMT6
Hydrochloric Acid SCHEMBL4376998 0.90 KMT2A (0.45) KMT2AMEN1FAAHCARM1PRMT6
SCHEMBL8218596 0.88 KMT2A (0.48) KMT2AMEN1LMNAKDM4EGAA
SCHEMBL8218922 0.88 HTR7 (0.52) KMT2APOLBLMNAMAPTALDH1A1
Hydrochloric Acid SCHEMBL4387884 0.87 KMT2A (0.48) KMT2AMEN1LMNAKDM4EGAA
SCHEMBL8218601 0.87 CARM1 (0.43) KMT2AMEN1CARM1PRMT6ALDH1A1
Hydrochloric Acid SCHEMBL4384778 0.87 HTR7 (0.51) KMT2APOLBLMNAMAPTALDH1A1
Hydrochloric Acid SCHEMBL4382723 0.86 CARM1 (0.43) KMT2AMEN1CARM1PRMT6ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF PURDUE PHARMA L.P. 2009-12-03 US disclosed
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF PURDUE PHARMA L.P. 2009-12-03 US disclosed
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF PURDUE PHARMA L.P. 2009-12-03 US disclosed
WO-2008008398-A2 OXIME COMPOUNDS AND THE USE THEREOF SHIONOGI & CO., LTD. (JP) 2008-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090298878-A1 OXIME COMPOUNDS AND THE USE THEREOF KCNN4, CACNA1A, KCNN3 KMT2A 2079/4885MEN1 3694/4885FAAH 1521/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.